A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

doi:10.1084/jem.176.5.1453

This Article

	Full Text (PDF, 469K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Traversari, C.
	Articles by Boon, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Traversari, C.
	Articles by Boon, T.


Social Bookmarking

	What's this?

ARTICLES

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

C Traversari, P van der Bruggen, IF Luescher, C Lurquin, P Chomez, A Van Pel, E De Plaen, A Amar-Costesec and T Boon
Ludwig Institute for Cancer Research, Brussels Branch, Belgium.

We have reported the identification of human gene MAGE-1, which directs the expression of an antigen recognized on a melanoma by autologous cytolytic T lymphocytes (CTL). We show here that CTL directed against this antigen, which was named MZ2-E, recognize a nonapeptide encoded by the third exon of gene MAGE-1. The CTL also recognize this peptide when it is presented by mouse cells transfected with an HLA-A1 gene, confirming the association of antigen MZ2-E with the HLA-A1 molecule. Other members of the MAGE gene family do not code for the same peptide, suggesting that only MAGE-1 produces the antigen recognized by the anti- MZ2-E CTL. Our results open the possibility of immunizing HLA-A1 patients whose tumor expresses MAGE-1 either with the antigenic peptide or with autologous antigen-presenting cells pulsed with the peptide.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Segal, N. H., Parsons, D. W., Peggs, K. S., Velculescu, V., Kinzler, K. W., Vogelstein, B., Allison, J. P. (2008). Epitope Landscape in Breast and Colorectal Cancer. Cancer Res. 68: 889-892 [Abstract] [Full Text]
Slingluff, C. L. Jr., Petroni, G. R., Chianese-Bullock, K. A., Smolkin, M. E., Hibbitts, S., Murphy, C., Johansen, N., Grosh, W. W., Yamshchikov, G. V., Neese, P. Y., Patterson, J. W., Fink, R., Rehm, P. K. (2007). Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting. Clin. Cancer Res. 13: 6386-6395 [Abstract] [Full Text]
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., Griekspoor, A., Mesman, E., Verreck, F. A., Spits, H., Schlom, J., van Veelen, P., Neefjes, J. J. (2006). Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. JEM 203: 1259-1271 [Abstract] [Full Text]
Jackson, H., Dimopoulos, N., Mifsud, N. A., Tai, T. Y., Chen, Q., Svobodova, S., Browning, J., Luescher, I., Stockert, L., Old, L. J., Davis, I. D., Cebon, J., Chen, W. (2006). Striking Immunodominance Hierarchy of Naturally Occurring CD8+ and CD4+ T Cell Responses to Tumor Antigen NY-ESO-1. J. Immunol. 176: 5908-5917 [Abstract] [Full Text]
van Baren, N., Bonnet, M.-C., Dreno, B., Khammari, A., Dorval, T., Piperno-Neumann, S., Lienard, D., Speiser, D., Marchand, M., Brichard, V. G., Escudier, B., Negrier, S., Dietrich, P.-Y., Maraninchi, D., Osanto, S., Meyer, R. G., Ritter, G., Moingeon, P., Tartaglia, J., van der Bruggen, P., Coulie, P. G., Boon, T. (2005). Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells. JCO 23: 9008-9021 [Abstract] [Full Text]
Luiten, R. M., Kueter, E. W.M., Mooi, W., Gallee, M. P.W., Rankin, E. M., Gerritsen, W. R., Clift, S. M., Nooijen, W. J., Weder, P., van de Kasteele, W. F., Sein, J., van den Berk, P. C.M., Nieweg, O. E., Berns, A. M., Spits, H., de Gast, G. C. (2005). Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous GM-CSF-Transduced Tumor Cells in Metastatic Melanoma Patients. JCO 23: 8978-8991 [Abstract] [Full Text]
Yoshiura, K., Nakaoka, T., Nishishita, T., Sato, K., Yamamoto, A., Shimada, S., Saida, T., Kawakami, Y., Takahashi, T. A., Fukuda, H., Imajoh-Ohmi, S., Oyaizu, N., Yamashita, N. (2005). Carbonic Anhydrase II Is a Tumor Vessel Endothelium-Associated Antigen Targeted by Dendritic Cell Therapy. Clin. Cancer Res. 11: 8201-8207 [Abstract] [Full Text]
Dieckmann, D., Schultz, E. S., Ring, B., Chames, P., Held, G., Hoogenboom, H. R., Schuler, G. (2005). Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. Int Immunol 17: 621-635 [Abstract] [Full Text]
Liu, G., Ying, H., Zeng, G., Wheeler, C. J., Black, K. L., Yu, J. S. (2004). HER-2, gp100, and MAGE-1 Are Expressed in Human Glioblastoma and Recognized by Cytotoxic T Cells. Cancer Res. 64: 4980-4986 [Abstract] [Full Text]
Nagorsen, D., Scheibenbogen, C., Marincola, F. M., Letsch, A., Keilholz, U. (2003). Natural T Cell Immunity against Cancer. Clin. Cancer Res. 9: 4296-4303 [Abstract] [Full Text]
Ayyoub, M., Rimoldi, D., Guillaume, P., Romero, P., Cerottini, J.-C., Valmori, D., Speiser, D. (2003). Tumor-reactive, SSX-2-specific CD8+ T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients. Cancer Res. 63: 5601-5606 [Abstract] [Full Text]
Admon, A., Barnea, E., Ziv, T. (2003). Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides. Mol. Cell. Proteomics 2: 388-398 [Abstract] [Full Text]
Nilges, K., Hohn, H., Pilch, H., Neukirch, C., Freitag, K., Talbot, P. J., Maeurer, M. J. (2003). Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein. J. Virol. 77: 5464-5474 [Abstract] [Full Text]
Parmiani, G., Castelli, C., Dalerba, P., Mortarini, R., Rivoltini, L., Marincola, F. M., Anichini, A. (2002). Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?. JNCI J Natl Cancer Inst 94: 805-818 [Abstract] [Full Text]
Knutson, K. L., Schiffman, K., Cheever, M. A., Disis, M. L. (2002). Immunization of Cancer Patients with a HER-2/neu, HLA-A2 Peptide, p369-377, Results in Short-lived Peptide-specific Immunity. Clin. Cancer Res. 8: 1014-1018 [Abstract] [Full Text]
Sosman, J. A., Unger, J. M., Liu, P.-Y., Flaherty, L. E., Park, M. S., Kempf, R. A., Thompson, J. A., Terasaki, P. I., Sondak, V. K. (2002). Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Impact of HLA Class I Antigen Expression on Outcome. JCO 20: 2067-2075 [Abstract] [Full Text]
Kufer, P., Zippelius, A., Lutterbuse, R., Mecklenburg, I., Enzmann, T., Montag, A., Weckermann, D., Passlick, B., Prang, N., Reichardt, P., Dugas, M., Kollermann, M. W., Pantel, K., Riethmuller, G. (2002). Heterogeneous Expression of MAGE-A Genes in Occult Disseminated Tumor Cells: A Novel Multimarker Reverse Transcription-Polymerase Chain Reaction for Diagnosis of Micrometastatic Disease. Cancer Res. 62: 251-261 [Abstract] [Full Text]
Harig, S., Witzens, M., Krackhardt, A. M., Trojan, A., Barrett, P., Broderick, R., Zauls, A. J., Gribben, J. G. (2001). Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues. Blood 98: 2999-3005 [Abstract] [Full Text]
Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., Finn, O. J. (2001). Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells. JEM 194: 1313-1324 [Abstract] [Full Text]
Sato, K., Torimoto, Y., Tamura, Y., Shindo, M., Shinzaki, H., Hirai, K., Kohgo, Y. (2001). Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice. Blood 98: 1852-1857 [Abstract] [Full Text]
Jager, D, Jager, E, Knuth, A (2001). Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J. Clin. Pathol. 54: 669-674 [Abstract] [Full Text]
Sadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Yamaguchi, H., Ohta, M., Fujie, T., Tanaka, F., Inoue, H., Takesako, K., Akiyoshi, T., Mori, M. (2001). Dendritic Cell Vaccination with MAGE Peptide Is A Novel Therapeutic Approach for Gastrointestinal Carcinomas. Clin. Cancer Res. 7: 2277-2284 [Abstract] [Full Text]
Hanada, K.-i., Perry-Lalley, D. M., Ohnmacht, G. A., Bettinotti, M. P., Yang, J. C. (2001). Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas. Cancer Res. 61: 5511-5516 [Abstract] [Full Text]
Velders, M. P., Weijzen, S., Eiben, G. L., Elmishad, A. G., Kloetzel, P.-M., Higgins, T., Ciccarelli, R. B., Evans, M., Man, S., Smith, L., Kast, W. M. (2001). Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine. J. Immunol. 166: 5366-5373 [Abstract] [Full Text]
Kessler, J. H., Beekman, N. J., Bres-Vloemans, S. A., Verdijk, P., van Veelen, P. A., Kloosterman-Joosten, A. M., Vissers, D. C.J., ten Bosch, G. J.A., Kester, M. G.D., Sijts, A., Drijfhout, J. W., Ossendorp, F., Offringa, R., Melief, C. J.M. (2001). Efficient Identification of Novel HLA-A*0201-presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen PRAME by Proteasome-mediated Digestion Analysis. JEM 193: 73-88 [Abstract] [Full Text]
Valmori, D., Dutoit, V., Rubio-Godoy, V., Chambaz, C., Liénard, D., Guillaume, P., Romero, P., Cerottini, J.-C., Rimoldi, D. (2001). Frequent Cytolytic T-Cell Responses to Peptide MAGE-A10254-262 in Melanoma. Cancer Res. 61: 509-512 [Abstract] [Full Text]
Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanovic, S., Ockert, D., Rammensee, H.-G., Rieber, E. P. (2000). Generation of Survivin-specific CD8+ T Effector Cells by Dendritic Cells Pulsed with Protein or Selected Peptides. Cancer Res. 60: 4845-4849 [Abstract] [Full Text]
Kobayashi, H., Wood, M., Song, Y., Appella, E., Celis, E. (2000). Defining Promiscuous MHC Class II Helper T-Cell Epitopes for the HER2/neu Tumor Antigen. Cancer Res. 60: 5228-5236 [Abstract] [Full Text]
Gaiger, A., Reese, V., Disis, M. L., Cheever, M. A. (2000). Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood 96: 1480-1489 [Abstract] [Full Text]
Chames, P., Hufton, S. E., Coulie, P. G., Uchanska-Ziegler, B., Hoogenboom, H. R. (2000). Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library. Proc. Natl. Acad. Sci. USA 97: 7969-7974 [Abstract] [Full Text]
Heidecker, L., Brasseur, F., Probst-Kepper, M., Gueguen, M., Boon, T., Van den Eynde, B. J. (2000). Cytolytic T Lymphocytes Raised Against a Human Bladder Carcinoma Recognize an Antigen Encoded by Gene MAGE-A12. J. Immunol. 164: 6041-6045 [Abstract] [Full Text]
Nakao, M., Shichijo, S., Imaizumi, T., Inoue, Y., Matsunaga, K., Yamada, A., Kikuchi, M., Tsuda, N., Ohta, K., Takamori, S., Yamana, H., Fujita, H., Itoh, K. (2000). Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTL. J. Immunol. 164: 2565-2574 [Abstract] [Full Text]
Oka, Y., Udaka, K., Tsuboi, A., Elisseeva, O. A., Ogawa, H., Aozasa, K., Kishimoto, T., Sugiyama, H. (2000). Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product. J. Immunol. 164: 1873-1880 [Abstract] [Full Text]
Ito, D., Ogasawara, K., Iwabuchi, K., Inuyama, Y., Onoe, K. (2000). Induction of CTL Responses by Simultaneous Administration of Liposomal Peptide Vaccine with Anti-CD40 and Anti-CTLA-4 mAb. J. Immunol. 164: 1230-1235 [Abstract] [Full Text]
Chiari, R., Foury, F., De Plaen, E., Baurain, J.-F., Thonnard, J., G. Coulie, P. (1999). Two Antigens Recognized by Autologous Cytolytic T Lymphocytes on a Melanoma Result from a Single Point Mutation in an Essential Housekeeping Gene. Cancer Res. 59: 5785-5792 [Abstract] [Full Text]
Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]
Yamazaki, K., Spruill, G., Rhoderick, J., Spielman, J., Savaraj, N., Podack, E. R. (1999). Small Cell Lung Carcinomas Express Shared and Private Tumor Antigens Presented by HLA-A1 or HLA-A2. Cancer Res. 59: 4642-4650 [Abstract] [Full Text]
Chaux, P., Luiten, R., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V., Schultz, E., Cornelis, G. R., Boon, T., van der Bruggen, P. (1999). Identification of Five MAGE-A1 Epitopes Recognized by Cytolytic T Lymphocytes Obtained by In Vitro Stimulation with Dendritic Cells Transduced with MAGE-A1. J. Immunol. 163: 2928-2936 [Abstract] [Full Text]
Bellone, G., Turletti, A., Artusio, E., Mareschi, K., Carbone, A., Tibaudi, D., Robecchi, A., Emanuelli, G., Rodeck, U. (1999). Tumor-Associated Transforming Growth Factor-{beta} and Interleukin-10 Contribute to a Systemic Th2 Immune Phenotype in Pancreatic Carcinoma Patients. Am. J. Pathol. 155: 537-547 [Abstract] [Full Text]
Rongcun, Y., Salazar-Onfray, F., Charo, J., Malmberg, K.-J., Evrin, K., Maes, H., Kono, K., Hising, C., Petersson, M., Larsson, O., Lan, L., Appella, E., Sette, A., Celis3, E., Kiessling, R. (1999). Identification of New HER2/neu-Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas. J. Immunol. 163: 1037-1044 [Abstract] [Full Text]
De Backer, O., Arden, K. C., Boretti, M., Vantomme, V., De Smet, C., Czekay, S., Viars, C. S., De Plaen, E., Brasseur, F., Chomez, P., Van den Eynde, B., Boon, T., van der Bruggen, P. (1999). Characterization of the GAGE Genes That Are Expressed in Various Human Cancers and in Normal Testis. Cancer Res. 59: 3157-3165 [Abstract] [Full Text]
Ronsin, C., Chung-Scott, V., Poullion, I., Aknouche, N., Gaudin, C., Triebel, F. (1999). A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ. J. Immunol. 163: 483-490 [Abstract] [Full Text]
Tanzarella, S., Russo, V., Lionello, I., Dalerba, P., Rigatti, D., Bordignon, C., Traversari, C. (1999). Identification of a Promiscuous T-Cell Epitope Encoded by Multiple Members of the MAGE Family. Cancer Res. 59: 2668-2674 [Abstract] [Full Text]
Huang, L.-Q., Brasseur, F., Serrano, A., De Plaen, E., van der Bruggen, P., Boon, T., Van Pel, A. (1999). Cytolytic T Lymphocytes Recognize an Antigen Encoded by MAGE-A10 on a Human Melanoma. J. Immunol. 162: 6849-6854 [Abstract] [Full Text]
Rohrer, J. W., Barsoum, A. L., Dyess, D. L., Tucker, J. A., Coggin, J. H. Jr. (1999). Human Breast Carcinoma Patients Develop Clonable Oncofetal Antigen-Specific Effector and Regulatory T Lymphocytes. J. Immunol. 162: 6880-6892 [Abstract] [Full Text]
Lake, D. F., Salgaller, M. L., van der Bruggen, P., Bernstein, R. M., Marchalonis, J. J. (1999). Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1. Int Immunol 11: 745-751 [Abstract] [Full Text]
Imro, M. A., Manici, S., Russo, V., Consogno, G., Bellone, M., Rugarli, C., Traversari, C., Protti, M. P. (1999). Major Histocompatibility Complex Class I Restricted Cytotoxic T Cells Specific for Natural Melanoma Peptides Recognize Unidentified Shared Melanoma Antigen(s). Cancer Res. 59: 2287-2291 [Abstract] [Full Text]
Maitre, N., Brown, J. M., Demcheva, M., Kelley, J. R., Lockett, M. A., Vournakis, J., Cole, D. J. (1999). Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination. Clin. Cancer Res. 5: 1173-1182 [Abstract] [Full Text]
Ayyoub, M., Mazarguil, H., Monsarrat, B., Van den Eynde, B., Gairin, J. E. (1999). A Structure-based Approach to Designing Non-natural Peptides That Can Activate Anti-melanoma Cytotoxic T Cells. J. Biol. Chem. 274: 10227-10234 [Abstract] [Full Text]
Baar, J. (1999). Clinical Applications of Dendritic Cell Cancer Vaccines. The Oncologist 4: 140-144 [Full Text]
Foon, K. A., Yannelli, J., Bhattacharya-Chatterjee, M. (1999). Colorectal Cancer as a Model for Immunotherapy. Clin. Cancer Res. 5: 225-236 [Full Text]
Gaudin, C., Kremer, F., Angevin, E., Scott, V., Triebel, F. (1999). A hsp70-2 Mutation Recognized by CTL on a Human Renal Cell Carcinoma. J. Immunol. 162: 1730-1738 [Abstract] [Full Text]
WEYNANTS, P., THONNARD, J., MARCHAND, M., DELOS, M., BOON, T., COULIE, P.�G. (1999). Derivation of Tumor-specific Cytolytic T-Cell Clones from Two Lung Cancer Patients with Long Survival. Am. J. Respir. Crit. Care Med. 159: 55-62 [Abstract] [Full Text]
Reynolds, S. R., Celis, E., Sette, A., Oratz, R., Shapiro, R. L., Johnston, D., Fotino, M., Bystryn, J.-C. (1998). HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients. J. Immunol. 161: 6970-6976 [Abstract] [Full Text]
Bohm, W., Thoma, S., Leithauser, F., Moller, P., Schirmbeck, R., Reimann, J. (1998). T Cell-Mediated, IFN-{gamma}-Facilitated Rejection of Murine B16 Melanomas. J. Immunol. 161: 897-908 [Abstract] [Full Text]
Gueguen, M., Patard, J.-J., Gaugler, B., Brasseur, F., Renauld, J.-C., Van Cangh, P. J., Boon, T., Van den Eynde, B. J. (1998). An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma. J. Immunol. 160: 6188-6194 [Abstract] [Full Text]
de Zoeten, E. F., Carr-Brendel, V., Cohen, E. P. (1998). Resistance to Melanoma in Mice Immunized with Semiallogeneic Fibroblasts Transfected with DNA from Mouse Melanoma Cells. J. Immunol. 160: 2915-2922 [Abstract] [Full Text]
Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C. A., Colella, T. A., Shabanowitz, J. A., Hunt, D. F., Engelhard, V. H., Slingluff, C. L. Jr. (1998). Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development. J. Immunol. 160: 2099-2106 [Abstract] [Full Text]
Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., Itoh, K. (1998). A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes. JEM 187: 277-288 [Abstract] [Full Text]
Osanto, S. (1997). Vaccine Trials for the Clinician: Prospects for Tumor Antigens. The Oncologist 2: 284-299 [Abstract] [Full Text]
Vierboom, M. P.M., Nijman, H. W., Offringa, R., Voort, E. I.H. v. d., Hall, T. v., Broek, L. v. d., Fleuren, G. J., Kenemans, P., Kast, W. M., Melief, C. J.M. (1997). Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes. JEM 186: 695-704 [Abstract] [Full Text]
Heiss, N S, Rogner, U C, Kioschis, P, Korn, B, Poustka, A (1996). Transcription mapping in a 700-kb region around the DXS52 locus in Xq28: isolation of six novel transcripts and a novel ATPase isoform (hPMCA5).. Genome Res 6: 478-491 [Abstract]
Luescher, I. F., Romero, P., Kuznetsov, D., Rimoldi, D., Coulie, P., Cerottini, J.-C., Jongeneel, C. V. (1996). HLA Photoaffinity Labeling Reveals Overlapping Binding of Homologous Melanoma-associated Gene Peptides by HLA-A1, HLA-A29, and HLA-B44. J. Biol. Chem. 271: 12463-12471 [Abstract] [Full Text]
Calenoff, E., Cheever, M. A., Satam, M., Dutra, J. C., Pelzer, H. J., Kern, R. C., Hanson, D. G. (1995). Serum Immunoglobulins Specific for Intracellular Proteins of Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg 121: 183-191 [Abstract]
Lanzavecchia, A (1993). Identifying strategies for immune intervention. Science 260: 937-944 [Abstract]